Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 450 of 506 entries
View as:

Filgrastim, Cladribine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes

Phase: N/A Priority: Normal
NCT ID: NCT02044796 Org: User:
Start: 01/23/14 End: 04/16/18 Due: 04/16/19

Conditioning Regimens for Patients With Severe Aplastic Anemia Transplanted With Marrow From an Unrelated Donor

Phase: N/A Priority: Normal
NCT ID: NCT00144729 Org: User:
Start: 05/31/93 End: 07/31/07 Due: 07/31/08

Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Persistent or Platinum Refractory Stage III or IV Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00003080 Org: User:
Start: 09/30/96 End: 05/31/01 Due: 05/31/02

Bone Marrow Transplantation in Treating Children With Sickle Cell Disease

Phase: N/A Priority: Normal
NCT ID: NCT00004485 Org: User:
Start: 12/31/99 End: - Due: -

Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00003199 Org: User:
Start: 11/30/97 End: 12/31/09 Due: 12/31/10

A Smartphone Application (ACT on Vaping) for Vaping Cessation in Young Adults

Phase: N/A Priority: Normal
NCT ID: NCT05897242 Org: User:
Start: 01/04/24 End: 04/26/24 Due: 04/26/25

Evaluation of Abemaciclib and Radiation Therapy Before Surgery for the Treatment of High-Risk Adipocytic Retroperitoneal Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT06025747 Org: User:
Start: 03/19/25 End: 03/03/29 Due: 03/03/30

HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT03326921 Org: User:
Start: 02/23/18 End: 07/16/28 Due: 07/16/29

Lenalidomide With or Without Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Who Have Undergone Autologous or Syngeneic Stem Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT00833534 Org: User:
Start: 02/28/09 End: - Due: -

Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00024050 Org: User:
Start: 02/28/01 End: 08/31/07 Due: 08/31/08

CD19 CAR T Cells for B Cell Malignancies After Allogeneic Transplant

Phase: N/A Priority: Normal
NCT ID: NCT01475058 Org: User:
Start: 04/30/12 End: 07/31/14 Due: 07/31/15

Vitamin D, Diet and Activity Study

Phase: N/A Priority: Normal
NCT ID: NCT01240213 Org: User:
Start: 10/31/10 End: 09/30/12 Due: 09/30/13

Vaccine Therapy Following Therapeutic Autologous Lymphocytes and Cyclophosphamide in Treating Patients With Metastatic Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT01339663 Org: User:
Start: 03/31/12 End: - Due: -

Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT00045292 Org: User:
Start: 04/30/02 End: 10/31/04 Due: 10/31/05

Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT00089037 Org: User:
Start: 06/30/03 End: 04/30/05 Due: 04/30/06

Communicating Health Information and Improving Coordination With Primary Care

Phase: N/A Priority: Normal
NCT ID: NCT03104543 Org: User:
Start: 03/01/17 End: 12/01/22 Due: 12/01/23

Biological Therapy in Treating Patients With Metastatic Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00045149 Org: User:
Start: 10/31/02 End: 06/30/05 Due: 06/30/06

Gemcitabine Hydrochloride, Carboplatin, Dexamethasone, and Rituximab in Treating Patients With Previously Treated Lymphoid Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT00072514 Org: User:
Start: 08/31/03 End: 11/30/13 Due: 11/30/14

Cyclophosphamide, Antithymocyte Globulin, and Total-Body Irradiation in Treating Patients With Severe Aplastic Anemia Undergoing Umbilical Cord Blood Transplant

Phase: N/A Priority: Normal
NCT ID: NCT00354419 Org: User:
Start: 02/28/06 End: - Due: -

Meals and Grazing Study

Phase: N/A Priority: Normal
NCT ID: NCT02548026 Org: User:
Start: 01/31/11 End: 06/30/12 Due: 06/30/13

Busulfan and Etoposide Followed by Peripheral Blood Stem Cell Transplant and Low-Dose Aldesleukin in Treating Patients With Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00003875 Org: User:
Start: 10/13/98 End: 06/11/15 Due: 06/11/16

Pharmacy-based PrEP Delivery in Kenya

Phase: N/A Priority: Normal
NCT ID: NCT05842122 Org: User:
Start: 06/20/23 End: 06/20/25 Due: 06/20/26

Vorinostat and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00673153 Org: User:
Start: 03/31/08 End: - Due: -

CLAG-M or FLAG-Ida Chemotherapy and Reduced-Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT04375631 Org: User:
Start: 12/03/20 End: 03/17/27 Due: 03/17/28

Genetic Information to Inform Treatment and Screening for Prostate Cancer, GIFTS Study

Phase: N/A Priority: Normal
NCT ID: NCT04254133 Org: User:
Start: 11/30/18 End: 08/31/28 Due: 08/31/29